Engineered therapeutic antibodies with mannose 6-phosphate analogues as a tool to degrade extracellular proteins
Inducing the degradation of pathological soluble antigens could be the key to greatly enhancing the efficacy of therapeutic monoclonal antibodies (mAbs), extensively used in the treatment of autoimmune and inflammatory disorders or cancer. Lysosomal ta…